Lv3
340 积分 2023-08-22 加入
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus
1个月前
已完结
EBV-associated lymphoproliferative disease post-CAR-T cell therapy
2个月前
已完结
Malignancies after chimeric antigen receptor T-cell therapy
2个月前
已完结
Current understanding and management of CAR T cell-associated toxicities
2个月前
已完结
Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs
4个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
7个月前
已关闭
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
7个月前
已关闭
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
9个月前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
10个月前
已完结
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
1年前
已完结
皖公网安备34019202002308
